RANDAL J KIRK Insider Trading $ZIOP ZIOPHARM ONCOLOGY INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for RANDAL J KIRK.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of RANDAL J KIRK. RANDAL J KIRK is Director in CLINICAL DATA INC ($NOVI) and 10% Owner in AmpliPhi Biosciences Corp ($APHB) and 10% Owner in Fibrocell Science, Inc. ($FCSC) and 10% Owner in SOLIGENIX, INC. ($DOR) and 10% Owner in Synthetic Biologics, Inc. ($SYN) and 10% Owner in TRANSGENOMIC INC ($TBIO) and Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and 10% Owner in HALOZYME THERAPEUTICS INC ($GYHT) and Director in HALOZYME THERAPEUTICS INC ($GYHT) and 10% Owner in ORAGENICS INC ($OGEN) and 10% Owner in INTREXON CORP ($XON) and Chief Executive Officer in INTREXON CORP ($XON) and Director in INTREXON CORP ($XON) and Executive Chairman in INTREXON CORP ($XON) and 10% Owner in HISTOGENICS CORP ($HSGX) and 10% Owner in AquaBounty Technologies, Inc. ($AQB).

RANDAL J KIRK in ZIOPHARM ONCOLOGY INC

Trading Symbol: ZIOP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RANDAL J KIRK: Director
Holdings: 139,513 shares
Current Value: $934,737
Latest Transaction: Oct 09 2018
$ZIOP Market Capitalization: $850.83M
$ZIOP Previous Close: $6.70

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of RANDAL J KIRK in ZIOPHARM ONCOLOGY INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AQB, APHB, NOVI, FCSC, GYHT, HSGX, OGEN, XON, PRPO, SNGX, SYN, ZIOP

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Oct 09 2018ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.00130,84900
Oct 09 2018ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.00130,84900
Sep 28 2018ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,2950130,849
Aug 31 2018ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,2820129,554
Jul 31 2018ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,2700128,272
Jun 29 2018ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,2570127,002
Jun 04 2018ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,2450125,745
Apr 30 2018ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,2320124,500
Mar 30 2018ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,2200123,268
Feb 28 2018ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,2080122,048
Jan 31 2018ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,1960120,840
Nov 30 2017ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,1720118,460
Nov 01 2017ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,1610117,288
Sep 29 2017ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,1490116,127
Aug 31 2017ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,1380114,978
Jul 31 2017ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,1270113,840
Jun 30 2017ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,1150112,713
Jun 01 2017ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,1040111,598
May 02 2017ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,0940110,494
Mar 31 2017ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,0830109,400
Mar 02 2017ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,0720108,317
Feb 02 2017ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,0610107,245
Dec 30 2016ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,0510106,184
Dec 30 2016ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorGrantA0.0017,2040139,513122.3 K to 139.5 K (+14.07 %)
Dec 01 2016ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,0400105,133
Nov 02 2016ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,0300104,093
Oct 04 2016ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,0200103,063
Sep 02 2016ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,0100102,043
Aug 02 2016ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,0330101,033
Jul 06 2016ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseP0.00100,0000100,000
Jan 04 2016ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorGrantA0.0026,6610122,30995.6 K to 122.3 K (+27.87 %)
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.0086,556086,5560 to 86.6 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.00173,1110173,1110 to 173.1 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.0058,746058,7460 to 58.7 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.00176,2380176,2380 to 176.2 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.00352,4770352,4770 to 352.5 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.00111,3390111,3390 to 111.3 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.00222,6800222,6800 to 222.7 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.00395,7910395,7910 to 395.8 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.00889,5130889,5130 to 889.5 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.001,013,14602,359,6081.3 M to 2.4 M (+75.25 %)
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.0061,262061,2620 to 61.3 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.00138,9750138,9750 to 139 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.00154,1810154,1810 to 154.2 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.0029,066029,0660 to 29.1 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.0034,318034,3180 to 34.3 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.00358,3860358,3860 to 358.4 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.00337,3330337,3330 to 337.3 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.009,53709,5370 to 9.5 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.0053,245053,2450 to 53.2 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.0024002400 to 240
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.0040,954040,9540 to 41 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.0023,504023,5040 to 23.5 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.0023,349023,3490 to 23.3 K
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorBuyJ0.003,479,00603,479,0060 to 3.5 M
Jun 08 2015ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorSellJ0.0017,830,3050017.8 M to 0 (-100.00 %)

Page:   1

Contact us | Follow us on Twitter